simulationName;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;Larson_2013_8y-18y_400mg_FCT_meal;R-square;pValue;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd;Filmcoated_tablet_400mg_sd
;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;5^{th}-Individual ID 4;;;95^{th}-Individual ID 82;95^{th}-Individual ID 82;95^{th}-Individual ID 82;95^{th}-Individual ID 82;95^{th}-Individual ID 82
;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape;;;Lipophilicity;Specific intestinal permeability (transcellular);Raltegravir-UGT1A9-Kassahun 2007|In vitro Vmax for liver microsomes;Raltegravir-UGT1A1-Kassahun 2007|In vitro Vmax for liver microsomes;Dissolution shape
;-0.40990952471332;0.0871538509530784;-0.306984049418249;-0.415001313944782;0.88194576304774;;;-0.385337665129924;0.0794409064080067;-0.226150801058804;-0.45567431340925;0.844564781130505
;-0.427376643580611;0.0815151351847568;-0.320113522432376;-0.439489289448398;0.854624330604456;;;-0.403124058202172;0.072098897293785;-0.233013626413943;-0.485142281953773;0.827176240932246
;-0.392442405846029;0.0927925667214;-0.293854576404121;-0.390513338441165;0.909267195491023;;;-0.367551272057676;0.0867829155222283;-0.219287975703665;-0.426206344864727;0.861953321328764
;0.999462433629513;0.998761636390474;0.999458464659265;0.998969712983183;0.999715816523757;;;0.999369307101963;0.997476268699723;0.999727296778322;0.99876276349159;0.999874453424697
;5.29062591618787e-06;1.85021653332664e-05;5.34933308114558e-06;1.40397861344233e-05;2.03340612494122e-06;;;6.7235395947551e-06;5.38496231382493e-05;1.91143617362531e-06;1.84769051091249e-05;5.97052508770323e-07
